Who invested in Akarna Therapeutics?
Akarna Therapeutics's investors include Forbion Capital Partners.
Funding summaryUpdated 26 Oct 2026
$15Mraised across 1 round since 2016, from 1 source
Akarna Therapeutics's investors include Forbion Capital Partners.
Akarna Therapeutics has raised $15M across 1 round since 2016.
Akarna Therapeutics's most recent round was a Series B of $15M in Feb 2016.
Its most recent round, $15M in Feb 2016, is also its largest on record.
Akarna Therapeutics's first round on record, in Feb 2016, was backed by Forbion Capital Partners.
Akarna Therapeutics's latest named round is a Series B, in Feb 2016.
Search every investor by what they have actually funded, then narrow to your stage and market. Free.